The GLP-1 boom is pushing companies across consumer industries to rethink what people eat, drink, and buy. Weight-loss drugs are creating new demand beyond the pharmaceutical sector. Companies now see opportunities in nutrition, food, beverages...
Pharmaceutical growth in India is entering a phase where CDMOs can play a larger role in shaping manufacturing, innovation, and global market access
India’s pharmaceutical sector opened FY27 with mixed but largely positive results across exports, domestic sales, and global markets. Pharma exports rose 6.8 percent year over year to USD 8.1 billion in Q1 FY27. Several drugmakers also...
Gland Pharma reported a strong Q1 profit. The company posted revenue of INR 1,800.27 crore in Q1 FY27. Its net profit rose 47.1% year over year to INR 316.95 crore.
India’s MedTech industry is entering a new phase of growth as domestic manufacturing, technology innovation, global partnerships, and healthcare demand reshape the medical devices sector.
Samsung Bioepis has launched its aflibercept biosimilar OPUVIZ in both vial and pre-filled syringe formats, marking an entry to Europe’s eye drug market
Akums Drugs and Pharmaceuticals has started FY27 on a strong note, with Q1 profit surging 55 percent year-on-year.
Medical device manufacturing in India is set to enter a new shift as the government strengthens its push to build an export-oriented ecosystem
Biocon delivered a strong start to FY27 with a sharp rise in earnings. The company's Q1 profit jumped four times year-on-year, supported by steady biosimilars demand. Revenue also increased, reflecting healthy growth across its key business segments.
Quarterly Earnings took the spotlight after Pfizer reported better-than-expected second-quarter results. However, the company made it clear that its focus extends beyond one strong quarter.
.jpg)
, CDSCO.jpg)